ASCVD vs CVD: Key Distinctions
ASCVD is a specific subset of CVD that includes only conditions caused by atherosclerosis, while CVD is a broader umbrella term encompassing all disorders of the heart and blood vessels, including non-atherosclerotic conditions. 1
What ASCVD Includes
ASCVD specifically refers to clinical manifestations of atherosclerotic plaque formation and includes: 2, 3, 1
- Coronary manifestations: Acute coronary syndromes, myocardial infarction (MI), stable or unstable angina, and angiographically documented coronary artery disease 1
- Cerebrovascular disease: Ischemic stroke, transient ischemic attack (TIA), and documented carotid artery disease 2, 1
- Peripheral vascular disease: Peripheral artery disease (PAD), abdominal aortic aneurysm of atherosclerotic origin 1
- Revascularization procedures: Any coronary artery bypass graft surgery, percutaneous coronary intervention, carotid endarterectomy, or other arterial revascularizations 1
The critical defining feature is that the condition must be atherosclerotic in origin—meaning caused by plaque buildup in arterial walls. 4
What CVD Includes Beyond ASCVD
CVD is the broader category that encompasses ASCVD plus additional cardiovascular conditions: 5, 6
- Heart failure (unless specifically caused by ischemic heart disease) 1, 6
- Atrial fibrillation 7, 1
- Valvular heart disease 1
- Non-ischemic cardiomyopathy 1
- Congenital heart disease 5
- Arrhythmias (other than those secondary to ischemia) 1
When researchers studied a contemporary primary prevention population, they found that ASCVD events accounted for only about half of all preventable cardiovascular events, with heart failure and coronary revascularization representing the most common additional CVD manifestations. 6
Clinical Implications of the Distinction
Risk stratification differs fundamentally: 7, 1
- ASCVD diagnosis automatically places patients in the secondary prevention category, mandating the most intensive risk-factor modification regardless of baseline lipid levels 1
- ASCVD status supersedes formal risk calculator scores and requires aggressive lipid-lowering therapy 1
- All ASCVD patients are automatically eligible for statin therapy 1
Primary prevention considerations: 8, 7
- For patients without ASCVD, the 10-year ASCVD risk calculation (using tools like the ACC/AHA Pooled Cohort Equations) guides treatment intensity for blood pressure and lipid management 8
- High-risk primary prevention patients (diabetes, chronic kidney disease, LDL-C ≥5.0 mmol/L) are statin-indicated but are NOT classified as having ASCVD until an atherosclerotic event occurs 1
Common Pitfalls to Avoid
Do not confuse subclinical atherosclerosis with clinical ASCVD: 1
- Coronary artery calcium scoring, carotid intima-media thickness, and asymptomatic plaques are risk enhancers for primary prevention, NOT indications for secondary prevention therapy 1
- These findings do not qualify as ASCVD for treatment categorization purposes 1
Verify atherosclerotic origin before assigning ASCVD status: 1
- Heart failure, arrhythmias, and valvular disease are NOT ASCVD unless they result directly from ischemic heart disease 1
- This distinction matters because ASCVD designation triggers more aggressive treatment protocols 3, 1
Very High-Risk ASCVD Category
Within ASCVD, a "very high-risk" designation exists for: 1
- Multiple major ASCVD events (e.g., MI plus stroke) 1
- Single major ASCVD event combined with multiple high-risk conditions (diabetes, chronic kidney disease, heart failure, age ≥65 years, hypertension, current smoking, or persistently elevated LDL-C despite maximal therapy) 1
- Recent acute coronary syndrome within the past 12 months 1
This very high-risk categorization guides even more intensive lipid-lowering targets, with recent evidence supporting LDL-C goals as low as <30 mg/dL in these patients. 9